8VCL

Crystal structure of HLA-A*03:01 in complex with a mutant PIK3CA peptide

8VCL の概要

• エントリーDOI: 10.2210/pdb8vcl/pdb
• 分子名称: HLA class I histocompatibility antigen, A alpha chain, Beta-2-microglobulin, Mutant PIK3CA peptide, ... (6 entities in total)
• 機能のキーワード: peptide-class i major histocompatibility complex, pmhc, immune system
• 由来する生物種: Homo sapiens (human); 詳細
• タンパク質・核酸の鎖数: 3
• 化学式量合計: 44756.49

構造登録者

Ma, J.,Baker, B.M. (登録日: 2023-12-14, 公開日: 2024-12-11, 最終更新日: 2025-07-09)

主引用文献

Ma, J.,Ayres, C.M.,Brambley, C.A.,Chandran, S.S.,Rosales, T.J.,Perera, W.W.J.G.,Eldaly, B.,Murray, W.T.,Corcelli, S.A.,Kovrigin, E.L.,Klebanoff, C.A.,Baker, B.M.
Dynamic allostery in the peptide/MHC complex enables TCR neoantigen selectivity.
Nat Commun, 16:849-849, 2025

PubMed Abstract: The inherent antigen cross-reactivity of the T cell receptor (TCR) is balanced by high specificity. Surprisingly, TCR specificity often manifests in ways not easily interpreted from static structures. Here we show that TCR discrimination between an HLA-A*03:01 (HLA-A3)-restricted public neoantigen and its wild-type (WT) counterpart emerges from distinct motions within the HLA-A3 peptide binding groove that vary with the identity of the peptide's first primary anchor. These motions create a dynamic gate that, in the presence of the WT peptide, impedes a large conformational change required for TCR binding. The neoantigen is insusceptible to this limiting dynamic, and, with the gate open, upon TCR binding the central tryptophan can transit underneath the peptide backbone to the opposing side of the HLA-A3 peptide binding groove. Our findings thus reveal a novel mechanism driving TCR specificity for a cancer neoantigen that is rooted in the dynamic and allosteric nature of peptide/MHC-I binding grooves, with implications for resolving long-standing and often confounding questions about T cell specificity.

PubMed: 39833157
DOI: 10.1038/s41467-025-56004-8

実験手法

X-RAY DIFFRACTION (2.4 Å)